Close this search box.

Clinical Guidelines

Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use In People with Diabetes (May 2023)

Date: May 2023 | Category: Type 2 Diabetes Mellitus |

Summary  The ADS together with ADEA and ANZCA have made an update to the Alert – ‘Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor use in People with Diabetes’ incorporating recently published data and clinical evidence. Please download published article in Diabetes Care, Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes, and the alert on periprocedural diabetic ketoacidosis (DKA) with SGLT2i use in people with diabetes developed by ADS, ADEA, DA, NZSSD and ANZCA.Alert
View the updated Alert (Posted: May, 2023)


Other Resources